SignatureFD’s Medtronic MDT Stock Holding History

SignatureFD’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,000	Closed	-$2K	–	2597
2020 Q1	$2K	Buy	+3,000	New	+$319K	﹤0.01%	1965

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SignatureFD's MDT Position: Q2 2026 in Review

SignatureFD reduced its Medtronic (MDT) stake by 19% in Q2 2026, selling an estimated $253K and leaving 13,268 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #429.

SignatureFD first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.75M in Q1 2022. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

SignatureFD held 13,268 shares of Medtronic worth $1.04M as of Q2 2026.
SignatureFD sold 3,135 Medtronic shares in Q2 2026, an estimated $253K.
Medtronic made up 0.01% of SignatureFD's portfolio in Q2 2026, its #429 holding.
SignatureFD first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
SignatureFD's Medtronic position peaked at $1.75M in Q1 2022.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.